IGF1 and central nervous system cancer: Furthermore, knockdown of endogenous β-catenin levels significantly attenuated IGF-1-induced cyclin D1 (Fig 1F) and cell growth (Fig 1G), suggesting that IGF-1 induced β-catenin signaling activation in glioma cells.